NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/22/2025
Back to search
Official data from USPTO
GENEVA OS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENEVA OS
ST13
US500000098182304Class
35, 38, 42, 44
Filing
98182304
Registration
7771675
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/23/2025
Trademark type
Word
Nice classes
35, 38, 42, 44
Filing date
09/15/2023
Registration date
04/22/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/22/2025
Last transaction
04/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/05/2023
First use in commerce
10/05/2023
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
RUIZ, AMANDA
Law office
O50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Atropos Health, Inc.
Representatives
Thomas Y. Yee PERKINS COIE LLP
Technical classification
Nice Classes
Class 35Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and data management in the field of clinical trialsproviding information management services by means of data compilation; collectionreportinganalysis of healthcare recordsclinical recordslife science report and article-related data for business purposes; services consisting of the registrationcollectiontranscriptioncompilationclarificationenablementenhancementmanagementmappingsystemization of written communications and data; all of the foregoing services may also be provided by means of artificial intelligence
Class 38
Providing access to an electronic exchange of health data and data analyses across an integrated nationwide clinical research network; transmission of health and medical record and life science report and article database information and analyses of health and medical record and life science report and articles database information via telecommunications networks; electronic exchange of health data and life science report and articles insights via telecommunication networks for analyses of health data from clinicianshealth systemsacademic medical centerslife sciences companiesothers; electronic transmission of health data; all of the foregoing services may also be provided by means of artificial intelligence
Class 42
Providing medicalhealthscientific research informationresearch dataresearch services to assist healthcare providershealthcare professionalslife sciences companies in making informed decisions for patient diagnosis and treatment and clinical trial designemulationstrategyprioritization; collectingstoringindexinganalyzingupdatingmanagingsharingreporting real world data to create actionable insights for use by healthcare providershealthcare professionalslife sciences companies; providing medical and scientific research information in the field of clinical trials and life sciences; compiling data for research purposes in the field of medical science and medical consultancy and life sciences; software as a service (SAAS) services featuring software for providing diagnosis and treatments recommendations for physicians and researchers; software as a service (SAAS) services featuring software for collectingstoringindexinganalyzingupdatingmanagingsharingclarifyingenablingenhancingmanagingmapping and reporting clinical trialdataelectronic health recordsclaims datalife science articles and reportmedical research data to evaluate and recommend medical diagnoses and treatments; software as a service (SAAS) services featuring software for searchingorganizing and managing datademographicsdiagnosesproceduresmedicationslaboratory valuesclinical notesmortalitylength of stay information for patients to inform clinical care decisions and research; software as a service (SAAS) services featuring software for providing healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; software as a service (SAAS) services featuring software for compilingclarifyingenablingenhancingmanagingmappinganalyzing medical records and heath data and life science articles and reports; software as a service (SAAS) services featuring software using a natural language or large language modelartificial intelligencemachine learning for compilingclarifyingenablingenhancingmanagingmapping and analyzing medical records and heath data and life science articles and reports; software as a service (SAAS) services featuring chatbot software using a natural language or large language model or artificial intelligence for compilingclarifyingenablingenhancingmanagingmappinganalyzing medical records and heath data and life science articles and reports and providing tailored reports regarding the data to physicians and researchers; compiling data for research purposes in the field of medical science and medical consultancy
Class 44
Providing medical information to healthcare providers and healthcare professionalslife sciences companies to help them make informed decisions for patient diagnosis and treatment and clinical trial designemulationstrategyprioritization; providing health data analysis to healthcare providers and healthcare professionals in the medical and patient-care industry to help them to assess clinical data for the purpose of patient diagnosis and treatment and improving quality of care in the medical and healthcare industry; providing information and data related to patient datademographicsdiagnosesproceduresmedicationslaboratory valuesclinical notesmortalitylength of stay information for patients to inform clinical care decisions and research and to inform life science company corporate strategyresearch and developmentmarketing and brand planning; providing on-line medical and clinical record and life science articles and reports analysis services designed to provide healthcare providers and healthcare professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; providing on-line medical and clinical record and life science articles and reports analysis services designed to provide medical providers with custom tailored information about the outcomes for patients with similar symptoms and evidence needed for patient care decisions; compilingclarifyingenablingenhancingmanagingmapping and analyzing medical and clinical data and life science articles and reports for medical treatment purposes; all of the foregoing services may also be provided by means of artificial intelligence
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/22/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/01/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/07/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/06/2025
EX1G
SOU EXTENSION 1 GRANTED
03/06/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/05/2025
IUAF
USE AMENDMENT FILED
12/24/2024
EISU
TEAS STATEMENT OF USE RECEIVED
12/24/2024
EXT1
SOU EXTENSION 1 FILED
12/20/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/20/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/21/2024
PUBO
PUBLISHED FOR OPPOSITION
05/21/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/28/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/28/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/28/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/03/2024
GNRT
NON-FINAL ACTION E-MAILED
01/03/2024
CNRT
NON-FINAL ACTION WRITTEN
01/03/2024
DOCK
ASSIGNED TO EXAMINER
12/18/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/04/2023
NWAP
NEW APPLICATION ENTERED
09/19/2023
Continuous trademark protection
Get notified about every new filing that threatens GENEVA OS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.